Skip to content

NIH AMP SCZ DPACC U24 eligibility Guide

Updated 8 official sources

Quick Answer: NIH AMP SCZ DPACC U24 eligibility is not broad: according to Simpler.Grants.gov, only Brigham and Women's Hospital may apply.

Full answer and how we checked it

Everyone else needs 4 facts from it: this is single-source, $5,000,000, clinical trial not allowed, and focused on data processing, analysis, and coordination for AMP SCZ. The 2026 decision turns on 7 checks.

Who this is for: Research offices, schizophrenia investigators, data-science teams, NIMH portfolio watchers, and business-development teams who need to know whether the AMP SCZ DPACC U24 is open to them or only useful as a partnership and market signal.

Data note: This guide uses the NIH AMP SCZ DPACC U24 opportunity (opens in a new tab), NIMH AMP SCZ program context (opens in a new tab), the NIMH Data Archive AMP SCZ collection (opens in a new tab), the live AMP SCZ DPACC program page, and Grantsights award-data signals checked again on June 2, 2026. On October 9, 2026, Grantsights rechecked the Grants.gov listing for RFA-MH-27-205 (opens in a new tab), the full announcement attached to it, and NIH RePORTER (opens in a new tab) records for the current DPACC award.

In this guide

Quick Facts

Agency
HHS
Last deadline
Jun 9, 2026 (passed)
Status
Closed

Assistance Listing 93.242: all awards

Source: USASpending.gov FY2024

These figures cover all National Institutes of Health awards under Assistance Listing 93.242, of every award type. They are not figures for the award this guide describes, and one award of that kind can be far smaller.

Total Awards (FY2024, whole listing)
6,220
Avg Award (whole listing)
$2,481,843
Median Award (whole listing)
$1,562,432
Total Funding (FY2024, whole listing)
$1.8B
YoY Funding Trend
-0.5%

Data last verified: May 18, 2026

According to Simpler.Grants.gov (opens in a new tab), RFA-MH-27-205 is a single-source NOFO, and only Brigham and Women's Hospital may apply. That means most searchers do not need encouragement. They need a fast stop signal and a better next step.

Use this guide with the live AMP SCZ DPACC program page, then compare it with NIH grants complete guide, NIH R01, R21, R03, and K awards, how grant reviewers score applications, what is a NOFO, and how to write a federal grant proposal. The answer for nearly every reader is "you can't apply," so this guide says it first.

June 2026 Source Check

Simpler.Grants.gov listed RFA-MH-27-205, posted May 7, 2026; the window closed June 9, 2026, with 1 expected award, $5,000,000 in program funding, no cost sharing, and only Brigham and Women's Hospital as the eligible applicant.

Source factWhat it means
Single-source applicantMost readers should not draft an application.
Closing dateJune 9, 2026 has closed; check the current notice for the next closing date before treating any internal timeline as active.
Funding signal$5,000,000 is useful market context, not broad competition evidence.
Clinical trial statusThe U24 is clinical trial not allowed.
Data roleThe work is data processing, analysis, and coordination for AMP SCZ.
Better pathsOther teams should compare R01, R21, data-use, collaboration, SBIR/STTR, or future NIMH routes.

A university schizophrenia lab, data vendor, or biomarker startup can still use the page as a portfolio signal, but the next click should be NIH grants complete guide, NIH mechanism comparison, or the live AMP SCZ DPACC program page, not an application package.

NIH AMP SCZ DPACC U24 Eligibility: 3 Stop Signals

3 stop signals come before any writing plan. First, only Brigham and Women's Hospital may apply. Second, non-U.S. entities are not eligible, non-U.S. components of U.S. organizations are not eligible, and foreign components are not allowed. Third, the opportunity is clinical trial not allowed.

Stop signalWhat it meansAction for most readers
Single-source applicantOnly Brigham and Women's Hospital may applyDo not write an application
Clinical trial not allowedThis is not an intervention trial routeLook for trial NOFOs elsewhere
DPACC roleData processing, analysis, and coordination are the workLook for collaboration or data-use paths

The common mistake is treating the presence of a live grant page as proof that any qualified schizophrenia data team can apply. They can't. This is a single-source continuation award for a named role, and the notice lists Renewal as the application type for Brigham and Women's Hospital.

Funding, Timing, and Award Math: $5M, 1 Award, June 9, 2026

$5,000,000 is listed as program funding, 1 expected award, and the award maximum. According to Simpler.Grants.gov, the closing date was June 9, 2026, the posted date was May 7, 2026, cost sharing was not required, and the instrument type was a cooperative agreement.

FactSource-backed read
Opportunity numberRFA-MH-27-205
Posted dateMay 7, 2026
Closing dateJune 9, 2026 (passed)
Program funding$5,000,000
Expected awards1
Award maximum$5,000,000

According to USAspending.gov (opens in a new tab) data, assistance listing 93.242 had about $1.77B in FY2024 obligations across 6,220 awards active that year. Those family numbers show large NIMH-adjacent research activity, but they should not be used to imply broad eligibility for this specific NOFO.

What the Full Announcement Adds: 3-Year Cap, No Budget Limit, December 2026 Start

The $5,000,000 figure comes from the Grants.gov synopsis, but the full announcement attached to the Grants.gov listing (opens in a new tab) says application budgets aren't limited and must reflect the project's actual needs. The maximum project period is 3 years. The earliest submission date was May 9, 2026, the due date was June 9, 2026 at 5:00 PM local time, late applications weren't accepted, and the NOFO expired June 10, 2026. Grants.gov set the listing to archive on August 8, 2026.

Step in the noticeDate or rule
Application types allowedNew, Renewal, Resubmission (Renewal named for Brigham and Women's Hospital)
Scientific merit reviewJuly 2026
National Advisory Mental Health CouncilOctober 2026
Earliest start dateDecember 2026
Data Management and Sharing PlanRequired, on the NIH DMS Plan format page (NIH recommends 2 pages)
NIMH Data ArchiveBudget for submitting common data elements to NDA
Steering CommitteeDPACC chairs it at least once every 2 weeks; budget travel for an annual in-person meeting

The notice explains why the award exists now. According to the full announcement, the AMP SCZ longitudinal study met its recruitment targets with more than 2,600 participants at clinical high risk, each followed for up to 24 months with clinical, cognitive, neurophysiology, neuroimaging, genetics, fluid biomarker, speech, facial expression, and digital measures. NIMH projects the full dataset won't be complete until June 2027, so this award keeps the processing pipeline, curation through the 24-month time points, and the primary analyses running.

How reviewers score the DPACC application

Peer review still applies to a single-source NOFO. The announcement says a non-meritorious application won't be funded, and reconsideration requests aren't accepted. Reviewers score these criteria separately:

  • Significance: whether the DPACC meets the needs of the research project it serves and whether its scope fits those needs.
  • Investigators: whether the PD/PIs have a record of managing multicenter collaborative research and coordinating clinical research, plus governance and conflict-resolution plans if there are multiple PIs.
  • Approach: the operational plan, organizational structure, benchmarks for success, workflow, and timeline, plus attention to biological variables such as sex.
  • Environment: institutional support and resources for electronic information handling.

Because the application is a renewal, the notice says reviewers will also weigh progress made in the last funding period. After review, funding turns on merit, available funds, and NIMH program priorities.

The Current DPACC Award in NIH RePORTER

Grantsights pulled NIH RePORTER on October 9, 2026. The existing DPACC is project U24MH124629 (opens in a new tab), titled Psychosis Risk Evaluation, Data Integration and Computational Technologies (PREDICT), at Brigham and Women's Hospital with Martha E. Shenton as contact PI. It began September 9, 2020 under RFA-MH-20-341. The FY2026 record (4U24MH124629-06) is a non-competing extension noticed May 18, 2026, with $5,221,430 in total costs ($4,236,482 direct) for June 1, 2026 through May 31, 2027.

The same hospital also holds a separate award, U24MH137171 (opens in a new tab), for the Clinical Trial DPACC under RFA-MH-24-151, with $7,083,201 in FY2026 and a project end date of May 31, 2029. Don't confuse the two. RFA-MH-27-205 concerns the longitudinal-study DPACC, not the clinical trial coordinating center. A related AMP SCZ clinical trial network award to Yale University, U01MH137298 (opens in a new tab) (ProCAN), shows $17,070,000 in FY2026.

AMP SCZ DPACC vs R01, R21, U24, and Data-Use Paths

5 nearby paths matter for users who cannot apply. The right next step is not to force a single-source application. It is to redirect the researcher to a route that matches their real role.

Reader situationBetter pathWhy
Named DPACC applicantAMP SCZ DPACC U24Single-source eligibility matches
External schizophrenia data scientistR01, R21, or data-use collaborationOwn research question may fit elsewhere
Clinical trial teamNIMH clinical-trial NOFOU24 is trial not allowed
Industry biomarker partnerPartnership or contract pathGrant eligibility may not fit
Research office tracking market signalsSave program page and monitor NIMHUseful for timing and portfolio context

For NIMH route choice, start with NIH grants complete guide and NIH R01, R21, R03, and K awards. If the team is still reading NOFOs loosely, what is a NOFO can prevent wasted work.

What NIH Doesn't Tell You

4 things remain unclear if a user only reads the listing. NIH says who can apply and what the DPACC does. It does not tell everyone else how to use the page.

First, NIH doesn't tell a non-eligible reader to stop in plain language. The eligibility text is there, but many users skim for deadline and dollar amount.

Second, NIH doesn't package the partnership signal. According to NIMH, AMP SCZ is built around clinical high-risk data, biomarker work, and shared analysis goals. A team that cannot apply may still have a future collaboration, methods, or data-use path.

Third, NIH doesn't compare DPACC with a normal R01. If you have an independent schizophrenia data question, you probably need a research-project route, not this U24.

Fourth, NIH doesn't explain the reputational risk of applying when the NOFO says only a named applicant is eligible. Don't spend institutional time on an application that the eligibility section already rules out.

5 Real-World AMP SCZ Scenarios

5 scenarios show what readers should do. The June 9, 2026 deadline has passed, so the only live question for Brigham and Women's Hospital is the July 2026 review and October 2026 council outcome. A university lab with a machine-learning schizophrenia project shouldn't draft a U24 application. It should look for an R01, R21, partnership, or data-access route.

ScenarioBest actionReason
Brigham DPACC teamTrack review and council outcomeApplicant rule matches; deadline passed
External university data labSeek R01/R21 or collaborationNot eligible for this NOFO
Clinical high-risk cohort siteExplore partnership signalsMay connect to AMP SCZ work
Digital biomarker startupLook for contracts, SBIR/STTR, or partnersCompany role may be indirect
Sponsored research officeFlag as no-apply for most PIsSaves time

For example, a PI with a psychosis prediction model who wants AMP SCZ data shouldn't chase the U24. The notice says DPACC uploads data with Globally Unique Identifiers to the NIMH Data Archive, so the realistic route is an NDA data-access request paired with an R01 or R21 that asks the PI's own question.

7 Draft Checks to Run First

7 checks only matter if the reader is the eligible applicant or supporting that team. Otherwise, stop after check 1.

  1. The applicant is Brigham and Women's Hospital.
  2. The application does not propose a clinical trial.
  3. The work centers on data processing, analysis, and coordination.
  4. The plan shows continuity from existing AMP SCZ networks.
  5. Data sharing and governance are clear.
  6. Staffing covers biomarker, clinical, analytic, and coordination tasks.
  7. The budget matches a $5,000,000 single award.

According to Simpler.Grants.gov, this NOFO listed $5,000,000, 1 expected award, and a June 9, 2026 closing date that has already passed. Grantsights analysis of USAspending.gov (opens in a new tab) FY2024 records puts the connected assistance listing, 93.242 Mental Health Research Grants, at about $1.77B in obligations across 6,220 awards active that year. That big number describes NIMH's whole research-grant listing, while the eligibility rule here admits one hospital.

7 Route Checks for RFA-MH-27-205

Checked against Simpler.Grants.gov (opens in a new tab), the NIMH AMP SCZ page (opens in a new tab), the NDA AMP SCZ collection (opens in a new tab), and the Grants.gov listing (opens in a new tab) on May 26, 2026, and rechecked on October 9, 2026.

CheckWhat the source saysWhat to do
EligibilityBrigham and Women's Hospital only; no foreign organizations or foreign componentsStop here unless you're on that team
StatusDue June 9, 2026; NOFO expired June 10, 2026Don't plan a submission
BudgetNot limited in the full announcement; $5,000,000 ceiling on the synopsisRead the full announcement, not just the synopsis
Project periodUp to 3 yearsExpect DPACC work to run past the June 2027 dataset completion
ReviewSignificance, Investigators, Approach, Environment, plus renewal progressNo reconsideration requests
DataDMS Plan (NIH recommends 2 pages); NDA uploads with GUIDsOutside teams should plan NDA access requests
Next actionCouncil review October 2026; earliest start December 2026Watch RePORTER for the award record

Final public checklist

  • Confirm whether U24 is the right route or whether a nearby program fits better.
  • If you want AMP SCZ data, check the NDA collection's access rules instead of this NOFO.

Sources

Largest awards active in FY2024

One row per recipient, its largest award | 6,220 Assistance Listing records | Avg: $2.5M

REAL DATA
1

The Johns Hopkins University

MD

$270.0M
2

Rutgers, the State University

NJ

$179.7M

Use the visible recipient rows as free source context

This program has no reviewed paid report today.

No reviewed paid report is currently offered for this program. The visible source rows remain free.

Next steps

Where to go next

These next pages help you move from research into a specific grant choice.

Frequently Asked Questions

Who is eligible for the NIH AMP SCZ DPACC U24?

The Simpler.Grants.gov listing says only Brigham and Women's Hospital may apply for this single-source NOFO.

How much funding is listed for AMP SCZ DPACC U24?

Simpler.Grants.gov lists $5,000,000 in program funding, 1 expected award, and a $5,000,000 award maximum.

When does AMP SCZ DPACC U24 close?

Simpler.Grants.gov listed a closing date of June 9, 2026, which has passed; check Simpler.Grants.gov for a reissued listing of this NOFO.

Does AMP SCZ DPACC U24 allow clinical trials?

No. RFA-MH-27-205 is listed as U24 Clinical Trial Not Allowed.

Who should read this if they cannot apply?

Most teams should use it as a market and partnership signal, then look for AMP SCZ data access, collaboration, schizophrenia R01/R21 routes, or NIMH data-analysis opportunities.

Last updated October 13, 2026. Corrected October 13, 2026: what changed. Published by Grantsights from public sources. See our editorial policy, how we build and check guides, corrections and how we make money.